CARDLYTICS INC - NOTE 1.000% 9/1

CUSIP: 14161WAB1

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Debt / NOTE 1.000% 9/1
Market price (% of par)
102.0%
Total 13F principal
$231,539,000
Principal change
+$1,988,000
Total reported market value
$236,000,000
Number of holders
13
Value change
+$1,267,578
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 14161WAB1?
CUSIP 14161WAB1 identifies 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q1 2022

As of 31 Mar 2022, CARDLYTICS INC - NOTE 1.000% 9/1 was held by 13 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $231,539,000 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, CAPSTONE INVESTMENT ADVISORS, LLC, GABELLI FUNDS LLC, GUARDIAN POINT CAPITAL, LP, 683 Capital Management, LLC, BARCLAYS PLC, Nicholas Investment Partners, LP, and Teton Advisors, Inc.. This page lists 13 institutional bondholders reporting positions for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.